20:04 EST Cathie Wood’s ARK Investment buys 653K shares of Recursion Pharmaceuticals (RXRX) today
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Strong Buy Recommendation for Recursion Pharmaceuticals: Leading Techbio Innovator with Robust Financials and Strategic AI Integration
- Recursion Pharmaceuticals price target lowered to $6 from $7 at Leerink
- Morning Movers: Bloom Energy higher following quarterly results
- Options Volatility and Implied Earnings Moves Today, February 28, 2025
- Recursion Pharmaceuticals Reports Strong 2024 Financial Results